Future Developments in Local Anesthetics Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Future Developments in Local Anesthetics. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Future Developments in Local Anesthetics Indian Medical PG Question 1: Anaesthetic agent causing analgesia?
- A. Thiopentone
- B. Ketamine (Correct Answer)
- C. Propofol
- D. Etomidate
Future Developments in Local Anesthetics Explanation: ***Ketamine***
- Ketamine provides excellent **analgesia** by acting as an **NMDA receptor antagonist**, making it unique among commonly used intravenous anesthetics [1].
- It induces a state of **dissociative anesthesia**, where the patient is conscious but detached from painful stimuli, maintaining cardiovascular stability [1].
*Thiopentone*
- Thiopentone is a **barbiturate** that causes rapid **induction of anesthesia** and profound **sedation** but has no analgesic properties.
- Its primary action is through potentiation of GABA-A receptor activity, leading to central nervous system depression.
*Propofol*
- Propofol is a widely used intravenous anesthetic known for its rapid onset and short duration of action, but it lacks significant **analgesic effects** [3].
- It primarily works by enhancing GABA-A receptor function, leading to **sedation** and hypnosis.
*Etomidate*
- Etomidate is an intravenous anesthetic characterized by its minimal cardiovascular depression, making it suitable for patients with **hemodynamic instability**, but it provides **no analgesia** [1], [2].
- Its anesthetic effect is mediated through GABA-A receptor potentiation, resulting in rapid loss of consciousness.
Future Developments in Local Anesthetics Indian Medical PG Question 2: What is the preferred concentration range of lidocaine for topical anesthesia?
- A. 2-4% (Correct Answer)
- B. 7-12%
- C. 12-15%
- D. <2%
Future Developments in Local Anesthetics Explanation: ***Correct Option: 2-4%***
- **Lidocaine** is an **amide-type local anesthetic** commonly used for topical anesthesia to numb localized areas before minor procedures.
- The **preferred concentration range for topical application is 2-4%**, which provides effective anesthesia with an acceptable safety profile.
- **2% lidocaine gel/cream** is commonly used for skin and genital mucosa.
- **4% lidocaine** is standard for oral and respiratory mucous membranes.
- **5% lidocaine patches** are used for post-herpetic neuralgia.
- This concentration range balances **clinical efficacy** with **minimal systemic toxicity risk**.
*Incorrect Option: <2%*
- Concentrations below **2%** are generally **suboptimal** for achieving significant topical anesthesia.
- These lower concentrations result in **insufficient pain relief** or require longer application times.
- While 0.5-1% solutions exist, they are primarily used for infiltration anesthesia, not topical application.
*Incorrect Option: 7-12%*
- Concentrations in the **7-12%** range are **too high** for routine topical use and increase the risk of **systemic toxicity**.
- These concentrations are not standard in clinical practice for general topical anesthesia.
- Higher concentrations increase absorption without proportional improvement in efficacy.
*Incorrect Option: 12-15%*
- Concentrations in the **12-15%** range are **excessively high** and pose substantial **risk of systemic absorption and toxicity**.
- Such high concentrations are **not recommended** for topical anesthesia in clinical practice.
- Even 10% sprays (used for oropharyngeal anesthesia) require strict dose limitations to prevent toxicity.
Future Developments in Local Anesthetics Indian Medical PG Question 3: Which of the following are theories of regional anesthesia
- A. Specificity Theory & Membrane Expansion Theory
- B. Specific Receptor Theory & Membrane Expansion Theory (Correct Answer)
- C. Specificity Theory & Gate Control Theory
- D. Specific Receptor Theory & Gate Control Theory
Future Developments in Local Anesthetics Explanation: ***Specific Receptor Theory & Membrane Expansion Theory***
- The **Specific Receptor Theory** proposes that local anesthetics bind to specific receptors on the **sodium channels**, preventing sodium influx and thus blocking nerve impulse conduction.
- The **Membrane Expansion Theory** suggests that local anesthetics incorporate into the nerve cell membrane, causing it to expand and **alter the conformation** of sodium channels, thereby impairing their function.
*Specificity Theory & Membrane Expansion Theory*
- **Specificity Theory** is not a recognized theory for the mechanism of action of regional anesthesia.
- While **Membrane Expansion Theory** is a recognized theory, it is paired with an incorrect option.
*Specificity Theory & Gate Control Theory*
- Neither **Specificity Theory** nor **Gate Control Theory** are primary mechanisms explaining the action of regional anesthetics.
- **Gate Control Theory** primarily addresses the modulation of pain signals in the dorsal horn of the spinal cord, not the direct nerve blocking action of local anesthetics.
*Specific Receptor Theory & Gate Control Theory*
- Although **Specific Receptor Theory** is a correct theory for regional anesthesia, it is incorrectly paired with the **Gate Control Theory**.
- **Gate Control Theory** explains how non-noxious stimuli can reduce pain perception, rather than the chemical blockade of nerve impulses.
Future Developments in Local Anesthetics Indian Medical PG Question 4: Which local anesthetic has the highest protein binding capacity?
- A. Tetracaine (Correct Answer)
- B. Procaine
- C. Lidocaine
- D. Prilocaine
Future Developments in Local Anesthetics Explanation: ***Tetracaine***
- **Tetracaine** has a very high protein binding capacity (around 80%), which correlates with its **long duration of action** and high potency.
- High protein binding means less free drug is available to reach nerve membranes immediately, but it also provides a reservoir for sustained release, contributing to its prolonged anesthetic effect.
*Lidocaine*
- **Lidocaine** has an intermediate protein binding capacity (around 60-70%), making it a **medium-duration** local anesthetic.
- Its protein binding is lower than tetracaine, hence it has a shorter clinical duration of action compared to tetracaine.
*Prilocaine*
- **Prilocaine** has a relatively low protein binding capacity (around 55%), leading to a **shorter duration of action** compared to lidocaine and tetracaine.
- Its lower protein binding also contributes to its relatively lower potency.
*Procaine*
- **Procaine** has the lowest protein binding capacity among the listed options (around 5-10%), making it a **short-acting** local anesthetic.
- Its rapid metabolism by plasma pseudocholinesterases further contributes to its limited duration of action.
Future Developments in Local Anesthetics Indian Medical PG Question 5: Which of the following inducing agent has analgesic property?
- A. Enflurane
- B. Halothane
- C. Sevoflurane
- D. Nitrous oxide (Correct Answer)
Future Developments in Local Anesthetics Explanation: ***Nitrous oxide***
- **Nitrous oxide** has significant **analgesic properties** due to its action on opioid receptors and NMDA receptor antagonism.
- It is frequently used as an adjuvant to other inhalational anesthetics to reduce their required dose and provide pain relief.
*Enflurane*
- While an inhalational anesthetic, **enflurane** primarily provides **anesthesia** and **muscle relaxation** with minimal analgesic properties at clinically relevant concentrations.
- It was associated with central nervous system stimulation (seizures) and is rarely used today.
*Halothane*
- **Halothane** is a potent volatile anesthetic that provides **muscle relaxation** and **anesthesia** but has very poor analgesic properties.
- Its use has largely been replaced due to concerns about **hepatotoxicity**.
*Sevoflurane*
- **Sevoflurane** is a commonly used volatile anesthetic known for its rapid onset and offset, making it suitable for induction and maintenance of anesthesia.
- However, its primary effect is **anesthesia** and it has very **limited analgesic properties** on its own.
Future Developments in Local Anesthetics Indian Medical PG Question 6: Interscalene approach to brachial plexus block does not provide optimal surgical anaesthesia in the area of distribution of which of the following nerve?
- A. Median
- B. Musculocutaneous
- C. Radial
- D. Ulnar (Correct Answer)
Future Developments in Local Anesthetics Explanation: ***Ulnar***
- The **ulnar nerve** (C8-T1) emerges from the lower trunk of the brachial plexus. During an **interscalene block**, the local anesthetic is typically deposited at the level of the roots and trunks (C5-C7), which is superior to the origin of the lower trunk that gives rise to the ulnar nerve.
- Due to the **cephalad spread** of the local anesthetic from an interscalene block, the **C8 and T1** nerve roots (and thus the ulnar nerve) are often not adequately blocked, leading to suboptimal anesthesia in its distribution.
*Median*
- The **median nerve** (C5-T1) originates from the lateral and medial cords, which are typically well-covered by the spread of local anesthetic in an interscalene block due to its formation from the middle and upper trunks.
- Optimal anesthesia in the distribution of the median nerve is generally achieved with an interscalene block, as its nerve roots are within the targeted antegrade spread.
*Musculocutaneous*
- The **musculocutaneous nerve** (C5-C7) arises from the lateral cord, which is formed by the upper and middle trunks. These structures are reliably blocked during an interscalene approach.
- Sensory and motor functions of the musculocutaneous nerve, such as **biceps contraction** and lateral forearm sensation, are usually well anesthetized.
*Radial*
- The **radial nerve** (C5-T1) is a branch of the posterior cord, which receives fibers from all three trunks. Its upper and middle trunk components are generally well-blocked by an interscalene approach.
- While complete anesthesia of the entire brachial plexus can be variable, the radial nerve is more consistently affected by an interscalene block than the ulnar nerve due to its more extensive proximal root contributions which are within the typical spread.
Future Developments in Local Anesthetics Indian Medical PG Question 7: Which of the following anesthetic agents have good analgesic property? a) Ketamine b) Nitrous oxide c) Thiopentone d) Propofol e) Midazolam
- A. Ketamine and Nitrous oxide (Correct Answer)
- B. Ketamine only
- C. Nitrous oxide and Thiopentone
- D. Ketamine and Propofol
- E. Midazolam only
Future Developments in Local Anesthetics Explanation: ***Ketamine and Nitrous oxide***
- **Ketamine** is a dissociative anesthetic with potent **analgesic properties** secondary to its action as an **NMDA receptor antagonist**.
- **Nitrous oxide** is an inhalational anesthetic known for its mild to moderate **analgesic effects**, making it useful for sedation and pain relief.
*Ketamine only*
- While **ketamine** has excellent analgesic properties, this option is incomplete as **nitrous oxide** also contributes significant analgesia among the choices.
- Excluding other agents with analgesic properties makes this option less comprehensive than the correct answer.
*Ketamine and Propofol*
- **Ketamine** possesses strong analgesic effects, but **propofol** is a sedative-hypnotic agent with no significant intrinsic **analgesic properties**.
- Propofol provides anesthesia and sedation but typically requires co-administration with opioids for pain control.
*Nitrous oxide and Thiopentone*
- **Nitrous oxide** provides analgesia, but **thiopentone** (a barbiturate) is primarily an anesthetic and sedative with **no significant analgesic properties**.
- Thiopentone can induce unconsciousness rapidly but does not relieve pain.
*Midazolam only*
- **Midazolam** is a benzodiazepine primarily used for sedation, anxiolysis, and amnesia, with **no intrinsic analgesic properties**.
- Its effects can reduce stress and perception of pain, but it does not directly act as an analgesic.
Future Developments in Local Anesthetics Indian Medical PG Question 8: Longest acting local anesthetic agent is -
- A. Bupivacaine (Correct Answer)
- B. Procaine
- C. Lidocaine
- D. Dibucaine
Future Developments in Local Anesthetics Explanation: ***Bupivacaine***
- **Bupivacaine** is the **longest-acting local anesthetic** in common clinical use, with a duration of action of **2-9 hours** (up to 12+ hours with epinephrine).
- Its prolonged effect is due to **high lipid solubility** and **extensive protein binding** (95%), allowing it to remain at the nerve site for an extended period.
- Widely used for **epidural anesthesia**, **spinal anesthesia**, and **peripheral nerve blocks** requiring prolonged analgesia.
*Dibucaine*
- Dibucaine, while theoretically long-acting, is **rarely used clinically** in modern practice.
- Primarily known as a **research tool** for testing plasma pseudocholinesterase activity (dibucaine number test).
- Not a standard answer for competitive medical examinations.
*Procaine*
- **Procaine** is a **short-acting** local anesthetic (30-60 minutes), primarily used for infiltration.
- Its rapid metabolism by **plasma pseudocholinesterase** limits its duration of action.
*Lidocaine*
- **Lidocaine** is an **intermediate-acting** local anesthetic (1-3 hours), widely used for various procedures due to its rapid onset and moderate duration.
- Its duration is significantly shorter than bupivacaine.
Future Developments in Local Anesthetics Indian Medical PG Question 9: A young male was administered regional anesthesia with 0.25% bupivacaine. The patient became unresponsive, and the pulse became unrecordable. What is the best management in this situation?
- A. ECPR with calcium
- B. ECPR with dobutamine
- C. ECPR with 20% intralipid (Correct Answer)
- D. ECPR with sodium bicarbonate
Future Developments in Local Anesthetics Explanation: ***ECPR with 20% intralipid***
- The scenario describes **Local Anesthetic Systemic Toxicity (LAST)**, likely due to bupivacaine, leading to cardiovascular collapse.
- **Intralipid 20%** is the first-line treatment for LAST-induced cardiovascular toxicity, as it acts as a lipid sink for the lipophilic local anesthetic.
*ECPR with calcium*
- While calcium may be used in certain cardiac arrest scenarios, it is **not the primary treatment for bupivacaine-induced cardiovascular collapse** and LAST.
- Calcium might offer some cardiac support but does not directly neutralize the local anesthetic's toxic effects.
*ECPR with dobutamine*
- **Dobutamine is an inotropic agent** used to improve cardiac contractility but is not indicated as a primary rescue therapy for severe LAST.
- It would not address the underlying toxicity caused by bupivacaine and could potentially worsen the situation by increasing myocardial oxygen demand without reversing toxin effects.
*ECPR with sodium bicarbonate*
- **Sodium bicarbonate** is used to treat metabolic acidosis and can be beneficial in certain drug overdoses to enhance excretion or stabilize cardiac membranes.
- However, it is **not the primary or most effective treatment for bupivacaine-induced LAST** and cardiovascular collapse compared to lipid emulsion therapy.
Future Developments in Local Anesthetics Indian Medical PG Question 10: Which nerve is targeted in the nasociliary nerve block?
- A. Greater palatine nerve
- B. Sphenopalatine nerve
- C. Anterior ethmoidal nerve
- D. Nasociliary nerve (Correct Answer)
Future Developments in Local Anesthetics Explanation: ***Nasociliary nerve***
- A nasociliary nerve block specifically targets the **nasociliary nerve** itself.
- This block is used to anesthetize the sensory innervation of structures supplied by the nasociliary nerve, such as parts of the **nasal cavity**, **eyeball**, and **skin of the nose**.
*Greater palatine nerve*
- The **greater palatine nerve** supplies sensation to the posterior hard palate and is targeted in a **greater palatine nerve block**.
- This nerve is a branch of the **maxillary nerve** and is primarily involved in dental and palatal anesthesia.
*Sphenopalatine nerve*
- The **sphenopalatine nerve**, or pterygopalatine ganglion, contains sensory fibers for the nasal cavity, palate, and pharynx, and its block is distinct from a nasociliary block.
- A **sphenopalatine ganglion block** is mainly used for conditions like cluster headaches and facial pain, not for direct eyeball sensation.
*Anterior ethmoidal nerve*
- The **anterior ethmoidal nerve** is a branch of the nasociliary nerve, but a nasociliary nerve block targets the main trunk, which includes all its branches.
- While the anterior ethmoidal nerve supplies the anterior part of the nasal septum and lateral wall, it is a **component** of the nasociliary innervation rather than the sole target.
More Future Developments in Local Anesthetics Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
